Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer
2694.6000 59.60 (2.26%)
NSE Apr 17, 2025 15:31 PM
Volume: 96,775
 

logo
Ajanta Pharma Ltd.
25 Jan 2017
2694.60
2.26%
HDFC Securities
Revenue increased by 2.52% to Rs. 515.02 Cr in Q3FY17 when compared to the previous quarter. Also, it increased by 9.68% when compared with Q3FY16
Number of FII/FPI investors increased from 373 to 385 in Mar 2025 qtr.
More from Ajanta Pharma Ltd.
Recommended